{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:41:30Z","timestamp":1788576090710,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03802-0","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:48:34Z","timestamp":1776502114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Defining pain trajectories in juvenile arthritis and associated patient characteristics"],"prefix":"10.1186","volume":"28","author":[{"given":"Maarten O.","family":"Mensink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sytze","family":"de Roock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Drylewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Jenniskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Eijkelkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"2","key":"3802_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","volume":"81","author":"S Thierry","year":"2014","unstructured":"Thierry S, et al. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81(2):112\u20137.","journal-title":"Joint Bone Spine"},{"issue":"9783","key":"3802_CR2","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138\u201349.","journal-title":"Lancet"},{"issue":"5","key":"3802_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-021-00590-6","volume":"17","author":"PA Nigrovic","year":"2021","unstructured":"Nigrovic PA, et al. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol. 2021;17(5):257\u201369.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"3802_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S2352-4642(19)30188-9","volume":"3","author":"SJW Shoop-Worrall","year":"2019","unstructured":"Shoop-Worrall SJW, et al. Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions. Lancet Child Adolesc Health. 2019;3(10):725\u201333.","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"3802_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.semarthrit.2015.10.008","volume":"45","author":"W Armbrust","year":"2016","unstructured":"Armbrust W, et al. Fatigue in patients with juvenile idiopathic arthritis: a systematic review of the literature. Semin Arthritis Rheum. 2016;45(5):587\u201395.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3802_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12969-016-0102-8","volume":"14","author":"GJ Bos","year":"2016","unstructured":"Bos GJ, et al. Physical activity in children with Juvenile Idiopathic Arthritis compared to controls. Pediatr Rheumatol Online J. 2016;14(1):42.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"3802_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10067-010-1444-0","volume":"30","author":"L Eyckmans","year":"2011","unstructured":"Eyckmans L, et al. What does it mean to grow up with juvenile idiopathic arthritis? A qualitative study on the perspectives of patients. Clin Rheumatol. 2011;30(4):459\u201365.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"3802_CR8","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3899\/jrheum.131536","volume":"41","author":"J Guzman","year":"2014","unstructured":"Guzman J, et al. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study J Rheumatol. 2014;41(11):2260\u20139.","journal-title":"A qualitative study J Rheumatol"},{"issue":"1","key":"3802_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12969-018-0276-3","volume":"16","author":"CG Schoemaker","year":"2018","unstructured":"Schoemaker CG, et al. Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol. Pediatr Rheumatol Online J. 2018;16(1):57.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"3802_CR10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.38223","volume":"66","author":"MH Bromberg","year":"2014","unstructured":"Bromberg MH, et al. Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study. Arthritis Rheumatol. 2014;66(2):462\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3802_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2217\/pmt.14.6","volume":"4","author":"MH Bromberg","year":"2014","unstructured":"Bromberg MH, et al. Persistent pain in chronically ill children without detectable disease activity. Pain Manag. 2014;4(3):211\u20139.","journal-title":"Pain Manag"},{"issue":"1","key":"3802_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/j.pain.0000000000001064","volume":"159","author":"NJ Shiff","year":"2018","unstructured":"Shiff NJ, et al. Trajectories of pain severity in juvenile idiopathic arthritis: results from the research in arthritis in Canadian children emphasizing outcomes cohort. Pain. 2018;159(1):57\u201366.","journal-title":"Pain"},{"issue":"4","key":"3802_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/acr.21850","volume":"65","author":"SM Tupper","year":"2013","unstructured":"Tupper SM, et al. Pain intensity variability and its relationship with quality of life in youths with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013;65(4):563\u201370.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3802_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12969-022-00719-1","volume":"20","author":"LSH Lim","year":"2022","unstructured":"Lim LSH, et al. Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials. Pediatr Rheumatol Online J. 2022;20(1):57.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"3802_CR15","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/art.43216","volume":"77","author":"S Ringold","year":"2025","unstructured":"Ringold S, et al. Three-year outcomes and latent class trajectory analysis of the childhood arthritis and rheumatology research alliance polyarticular JIA consensus treatment plans study. Arthritis Rheumatol. 2025;77(10):1433\u201341.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3802_CR16","doi-asserted-by":"publisher","first-page":"e003759","DOI":"10.1136\/rmdopen-2023-003759","volume":"10","author":"V Rypdal","year":"2024","unstructured":"Rypdal V, et al. Disease activity trajectories from childhood to adulthood in the population-based Nordic juvenile idiopathic arthritis cohort. RMD Open. 2024;10(1):e003759.","journal-title":"RMD Open"},{"issue":"1","key":"3802_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12871-025-02941-2","volume":"25","author":"S Atefeh","year":"2025","unstructured":"Atefeh S. Barriers and facilitators of pain management in children: a scoping review. BMC Anesthesiol. 2025;25(1):148.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"3802_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-025-01072-9","volume":"23","author":"R Naddei","year":"2025","unstructured":"Naddei R, et al. Clinical insights into heterogeneity of rheumatoid factor negative polyarticular juvenile idiopathic arthritis across the world. Pediatr Rheumatol Online J. 2025;23(1):30.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3802_CR19","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","volume":"12","author":"HL Nguena Nguefack","year":"2020","unstructured":"Nguena Nguefack HL, et al. Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. Clin Epidemiol. 2020;12:1205\u201322.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"3802_CR20","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2017-212104","volume":"77","author":"JF Swart","year":"2018","unstructured":"Swart JF, et al. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018;77(3):336\u201342.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"3802_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00296-018-3971-y","volume":"38","author":"N Wulffraat","year":"2018","unstructured":"Wulffraat N, et al. The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR). Rheumatol Int. 2018;38(Suppl 1):139\u201346.","journal-title":"Rheumatol Int"},{"issue":"2","key":"3802_CR22","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"issue":"8","key":"3802_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.ard.2025.01.013","volume":"84","author":"V Rypdal","year":"2025","unstructured":"Rypdal V, et al. Physician\u2019s global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force. Ann Rheum Dis. 2025;84(8):1425\u201336.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3802_CR24","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3899\/jrheum.100930","volume":"38","author":"G Filocamo","year":"2011","unstructured":"Filocamo G, et al. A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile arthritis multidimensional assessment report. J Rheumatol. 2011;38(5):938\u201353.","journal-title":"J Rheumatol"},{"issue":"1","key":"3802_CR25","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1038\/s41467-023-42834-x","volume":"14","author":"W Feng","year":"2023","unstructured":"Feng W, et al. NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing. Nat Commun. 2023;14(1):7238.","journal-title":"Nat Commun"},{"issue":"1686","key":"3802_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"HAM Wickham","year":"2019","unstructured":"Wickham HAM, Bryan J, et al. Welcome to the Tidyverse. JOSS. 2019;4(1686):1686.","journal-title":"JOSS"},{"key":"3802_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.18637\/jss.v078.i02","volume":"78","author":"CPV Proust-Lima","year":"2017","unstructured":"Proust-Lima CPV, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Soft. 2017;78:156.","journal-title":"J Stat Soft"},{"issue":"28","key":"3802_CR28","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1523\/JNEUROSCI.0092-16.2016","volume":"36","author":"N Eijkelkamp","year":"2016","unstructured":"Eijkelkamp N, et al. IL4-10 fusion protein is a novel drug to treat persistent inflammatory pain. J Neurosci. 2016;36(28):7353\u201363.","journal-title":"J Neurosci"},{"issue":"5","key":"3802_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/bph.13698","volume":"174","author":"N Ito","year":"2017","unstructured":"Ito N, et al. miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down-regulation. Br J Pharmacol. 2017;174(5):386\u201395.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"3802_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nn.2488","volume":"13","author":"YH Suh","year":"2010","unstructured":"Suh YH, et al. A neuronal role for SNAP-23 in postsynaptic glutamate receptor trafficking. Nat Neurosci. 2010;13(3):338\u201343.","journal-title":"Nat Neurosci"},{"issue":"12","key":"3802_CR31","doi-asserted-by":"publisher","first-page":"e28205","DOI":"10.1371\/journal.pone.0028205","volume":"6","author":"N Uceyler","year":"2011","unstructured":"Uceyler N, et al. IL-4 deficiency is associated with mechanical hypersensitivity in mice. PLoS ONE. 2011;6(12):e28205.","journal-title":"PLoS ONE"},{"issue":"3","key":"3802_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1471-4159.2010.07121.x","volume":"116","author":"Y Zhou","year":"2011","unstructured":"Zhou Y, et al. Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem. 2011;116(3):406\u201314.","journal-title":"J Neurochem"},{"issue":"23","key":"3802_CR33","doi-asserted-by":"publisher","first-page":"12575","DOI":"10.3390\/ijms252312575","volume":"25","author":"CH Wen","year":"2024","unstructured":"Wen CH, Kang HY, Chan JYH. Brain amyloid-beta peptide is associated with pain intensity and cognitive dysfunction in osteoarthritic patients. Int J Mol Sci. 2024;25(23):12575.","journal-title":"Int J Mol Sci"},{"key":"3802_CR34","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","volume":"10","author":"AG Vanderwall","year":"2019","unstructured":"Vanderwall AG, Milligan ED. Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management. Front Immunol. 2019;10:3009.","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"3802_CR35","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1097\/01.j.pain.0000460344.54470.20","volume":"156","author":"F Birklein","year":"2015","unstructured":"Birklein F, Schlereth T. Complex regional pain syndrome-significant progress in understanding. Pain. 2015;156(Suppl 1):S94\u2013103.","journal-title":"Pain"},{"issue":"3","key":"3802_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s11481-020-09970-3","volume":"16","author":"J Royds","year":"2021","unstructured":"Royds J, et al. An investigation into proteomic constituents of cerebrospinal fluid in patients with chronic peripheral neuropathic pain medicated with opioids- a pilot study. J Neuroimmune Pharmacol. 2021;16(3):634\u201350.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1\u20132","key":"3802_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pain.2007.07.031","volume":"132","author":"N Uceyler","year":"2007","unstructured":"Uceyler N, et al. Differential expression patterns of cytokines in complex regional pain syndrome. Pain. 2007;132(1\u20132):195\u2013205.","journal-title":"Pain"},{"key":"3802_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8069-2-6","volume":"2","author":"S Hao","year":"2006","unstructured":"Hao S, et al. Hsv-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain. 2006;2:6.","journal-title":"Mol Pain"},{"issue":"8","key":"3802_CR39","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/glia.23340","volume":"66","author":"H Okutani","year":"2018","unstructured":"Okutani H, et al. Recombinant interleukin-4 alleviates mechanical allodynia via injury-induced interleukin-4 receptor alpha in spinal microglia in a rat model of neuropathic pain. Glia. 2018;66(8):1775\u201387.","journal-title":"Glia"},{"issue":"32","key":"3802_CR40","doi-asserted-by":"publisher","first-page":"24968","DOI":"10.1074\/jbc.M110.145813","volume":"285","author":"SB Condliffe","year":"2010","unstructured":"Condliffe SB, et al. Endogenous SNAP-25 regulates native voltage-gated calcium channels in glutamatergic neurons. J Biol Chem. 2010;285(32):24968\u201376.","journal-title":"J Biol Chem"},{"issue":"11","key":"3802_CR41","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1038\/s41380-021-01166-2","volume":"26","author":"B Das","year":"2021","unstructured":"Das B, et al. Bace1 controls synaptic function through modulating release of synaptic vesicles. Mol Psychiatry. 2021;26(11):6394\u2013410.","journal-title":"Mol Psychiatry"},{"key":"3802_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2020.10.004","volume":"230","author":"A Dopico-Lopez","year":"2021","unstructured":"Dopico-Lopez A, et al. Inhibition of endogenous blood glutamate oxaloacetate transaminase enhances the ischemic damage. Transl Res. 2021;230:68\u201381.","journal-title":"Transl Res"},{"issue":"3","key":"3802_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/10705511.2016.1247646","volume":"24","author":"MS Rens van de Schoot","year":"2017","unstructured":"Rens van de Schoot MS, Winter SD, Depaoli S, Vermunt JK. The GRoLTS-checklist: guidelines for reporting on latent trajectory studies. Struct Equ Modeling. 2017;24(3):451\u201367.","journal-title":"Struct Equ Modeling"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03802-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03802-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:01:49Z","timestamp":1783476109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03802-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3802"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03802-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients were included in the Pharmachild study (IRB no. 11- 499) and\/or the UCAN CAN-DU study (IRB no. 18\u2013474). The studies were reviewed and approved by NedMec (Utrecht, the Netherlands).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}